Companies
PayPal Raises Full-Year Profit Forecast Amid Resilient Consumer Spending and Cost-Cutting Measures
Despite Challenges, PayPal Leverages Operational Efficiency to Project Strong Growth PayPal (PYPL) has once again raised its forecast for full-year...
Corbus Pharmaceuticals: Pioneering Next-Generation Therapies in Cancer and Obesity
Revolutionary Treatments on the Horizon with CRB-701 and CRB-913 Corbus Pharmaceutical (CRPB), an early-stage clinical biotechnology company, is making significant...
Delta Airlines Seeks Legal Recourse Against CrowdStrike and Microsoft Following Costly Outage
Historic Software Glitch Prompts Potential Lawsuit with Prominent Attorney David Boies at the Helm Delta Airlines (DAL) has taken a...
Apple Unveils Apple Intelligence: A Leap Forward in AI Integration
Apple's New AI Suite Set to Revolutionize User Experience and Drive Upgrades On Monday, Apple released the first version of...
TARS Pharmaceuticals: XDEMVY Eye Drops Set for Strong Performance in 2Q24 Amid Strategic Sales Expansion
Anticipated Growth in XDEMVY Sales, Sales Force Expansion, and Promising Pipeline Signal a Bright Future for TARS Pharmaceuticals As we...
McDonald’s Q2 Earnings Miss Expectations as Same-Store Sales Decline
Fast-Food Giant Faces Challenges Amid Consumer Spending Cuts Mc Donald’s (MCD) reported its second-quarter earnings on Monday, revealing results that...
Why Are These Stocks Surging Today?
Examining the Unprecedented Moves of Windtree Therapeutics, Regencell Therapeutics, and Coursera In the ever-fluctuating stock market, certain companies stand out...
Royal Caribbean Reinstates Dividends Amid Surging Demand
Strong Travel Demand Fuels Financial Growth and Shareholder Payouts Royal Caribbean Cruises (RCL) has become the first major cruise operator...
Trump Raises Over $4 Million in Cryptocurrencies Ahead of Major Bitcoin Conference
Crypto Donations Highlight Trump’s New Pro-Blockchain Stance and Campaign Strategy Former President Donald Trump is set to headline a significant...
Viking Therapeutics Advances Multiple Therapies Amid Strong Clinical Progress and Financial Stability
Obesity Drug VK2735 to Enter Phase 3, NASH Therapy VK2809 Shows Promising Results, and Novel Treatments in Development Viking Therapeutics...
